Zhilin Chen

Title: Zhilin Chen: Innovator in Pharmaceutical Compositions

Introduction

Zhilin Chen is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions. With a total of 5 patents to his name, Chen's work focuses on enhancing the stability and bioavailability of pharmaceutical compounds.

Latest Patents

Chen's latest patents include innovative formulations that utilize TLR7 agonists. One notable patent describes a solid pharmaceutical composition comprising a TLR7 agonist, specifically 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine. This composition is recognized for its excellent stability and dissolution properties. Another significant patent involves a solid pharmaceutical composition containing a 1,3,5-triazine derivative or its pharmaceutically acceptable salt. This formulation demonstrates good stability, a fast dissolution rate, and high bioavailability, making it suitable for clinical production and use.

Career Highlights

Throughout his career, Zhilin Chen has worked with notable companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Centaurus Biopharma Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Chen has collaborated with several professionals in his field, including Fei Liu and Song Tang. These collaborations have further enriched his research and development efforts in pharmaceutical compositions.

Conclusion

Zhilin Chen's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to influence the development of effective pharmaceutical compositions that enhance patient care.